
Morepen Laboratories Ltd Sees Surge in Value Trading and Institutional Interest
2026-08-06 12:00:07Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading activity and price performance, driven by robust institutional interest and significant value turnover. The stock’s recent rally, marked by a 4.59% gain on 6 August 2026, underscores growing investor confidence amid a broader sector outperformance.
Read full news article
Morepen Laboratories Ltd Surges 7.16% to Day's High of Rs 82.75 — Outperforms Sector by 6.82 Percentage Points
2026-08-06 11:03:10The Sensex edged up 0.20% on 6 Aug 2026, but Morepen Laboratories Ltd outpaced the broader market with a robust 7.16% gain, reaching an intraday high of Rs 82.75. This 6.82-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Broad-Based Technical Strength Lifts Morepen Laboratories Ltd to 52-Week High of Rs 79.6
2026-08-06 10:07:54With a sustained rally that has propelled Morepen Laboratories Ltd to a fresh 52-week high of Rs 79.6 on 6 Jun 2026, the stock’s momentum is unmistakable. This surge reflects a 38.24% gain over the past five trading sessions, underscoring a powerful technical alignment that has investors and analysts alike taking note.
Read full news article
Morepen Laboratories Sees Exceptional Volume Surge Amidst Strong Price Momentum
2026-08-06 10:00:25Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by volume on 6 August 2026. The stock recorded a remarkable surge in trading activity, accompanied by a steady price appreciation, signalling heightened investor interest and potential accumulation in the counter.
Read full news articleAre Morepen Laboratories Ltd latest results good or bad?
2026-08-05 19:24:10Morepen Laboratories Ltd's Q1 FY27 results indicate a significant operational turnaround, with a marked increase in both revenue and profitability. The company reported a revenue of ₹570.13 crores, reflecting a year-on-year growth of 34.07% and a sequential increase of 17.62% from the previous quarter. This quarter's revenue represents the highest quarterly sales figure recorded by Morepen, showcasing a robust upward trend in sales performance. The net profit for the quarter surged to ₹56.40 crores, representing a substantial year-on-year increase of 424.65% and a sequential growth of 258.32%. This dramatic rise in profitability is accompanied by an operating margin of 14.48%, which is a notable improvement from 5.69% in the same quarter last year, indicating enhanced operational efficiency and a favorable product mix. Despite these strong quarterly results, the company faces questions regarding the susta...
Read full news article
Morepen Laboratories Ltd Surges on High-Value Trading and Institutional Interest
2026-08-05 10:00:11Morepen Laboratories Ltd witnessed a remarkable surge in trading activity on 5 August 2026, emerging as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector. The stock recorded a significant 6.99% gain intraday, supported by robust institutional participation and a strong order flow that propelled it to a new 52-week high.
Read full news article
Morepen Laboratories Ltd Sees Exceptional Volume Surge Amidst Strong Price Gains
2026-08-05 10:00:11Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed an extraordinary surge in trading volume on 5 August 2026, accompanied by a notable price rally that outperformed its sector peers and broader market indices. This heightened activity signals renewed investor interest and potential accumulation in the stock, following a recent upgrade in its mojo grade.
Read full news article
Broad-Based Technical Strength Lifts Morepen Laboratories Ltd to 52-Week High of Rs 78.21
2026-08-05 09:53:12Surging past its previous peaks, Morepen Laboratories Ltd touched a new 52-week high of Rs 78.21 on 5 Jun 2026, marking a remarkable rally of over 130% from its 52-week low of Rs 33.44. This breakout is underpinned by a confluence of strong technical indicators and sustained price momentum, setting the stage for a notable phase in the stock’s trajectory.
Read full news article
Morepen Laboratories Ltd Surges 8.58% to Day's High of Rs 78.21 — Outperforms Sector by 10.58 Percentage Points
2026-08-05 09:31:43The Sensex edged up 0.50% while Morepen Laboratories Ltd surged 8.58% on 05 Jun 2026, hitting a new 52-week high of Rs 78.21. This 10.58-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.
Read full news articleMorepen Laboratories Limited - Outcome of Board Meeting
13-Nov-2019 | Source : NSEMorepen Laboratories Limited has informed the Exchange regarding Board meeting held on November 13, 2019.
Morepen Laboratories Limited - Updates
25-Sep-2019 | Source : NSEMorepen Laboratories Limited has informed the Exchange regarding 'Order Passed by SEBI'.
Shareholders meeting
24-Sep-2019 | Source : NSE
| Morepen Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 19, 2019 |
Corporate Actions
No Upcoming Board Meetings
Morepen Laboratories Ltd has declared 10% dividend, ex-date: 29 Aug 25
No Splits history available
No Bonus history available
No Rights history available






